Clinical Trial Update: Blepharospasm Short Interval [Phase 2]

View source ↗

Summary

A Phase 2 trial for blepharospasm sponsored by Merz Pharmaceuticals was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharospasm

Snippet

Sponsor: Merz Pharmaceuticals GmbH | Conditions: Blepharospasm | Phase 2 | Status: TERMINATED